The functions of long noncoding RNAs on regulation of F-box proteins in tumorigenesis and progression.
F-box protein
cancer
lncRNAs
noncoding RNA
oncogenesis
treatment
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
07
06
2022
accepted:
27
06
2022
entrez:
5
8
2022
pubmed:
6
8
2022
medline:
6
8
2022
Statut:
epublish
Résumé
Accumulated evidence has revealed that F-box protein, a subunit of SCF E3 ubiquitin ligase complexes, participates in carcinogenesis and tumor progression
Identifiants
pubmed: 35928868
doi: 10.3389/fonc.2022.963617
pmc: PMC9343830
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
963617Informations de copyright
Copyright © 2022 Xia, Chen, Huang, Mei and Lin.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Oncogene. 2017 Jun 8;36(23):3312-3321
pubmed: 28068319
Oncol Lett. 2021 Aug;22(2):604
pubmed: 34188706
Cell Death Dis. 2019 Dec 11;10(12):947
pubmed: 31827076
BMC Cancer. 2020 Mar 30;20(1):258
pubmed: 32228518
J Cell Biochem. 2020 Feb 26;:
pubmed: 32100921
BMC Cancer. 2021 Jun 29;21(1):753
pubmed: 34187411
Cancer Lett. 2019 Dec 1;466:61-70
pubmed: 31546023
Am J Cancer Res. 2016 Nov 01;6(11):2561-2574
pubmed: 27904771
J Clin Lab Anal. 2021 Dec;35(12):e24106
pubmed: 34762771
Neoplasma. 2020 Jul;67(4):751-761
pubmed: 32305055
Am J Cancer Res. 2022 Apr 15;12(4):1456-1464
pubmed: 35530293
Onco Targets Ther. 2020 Jun 30;13:6295-6302
pubmed: 32636648
Gen Physiol Biophys. 2020 Jan;39(1):59-67
pubmed: 32039825
Yonsei Med J. 2019 Oct;60(10):905-913
pubmed: 31538425
Drug Resist Updat. 2020 May;50:100683
pubmed: 32146422
Cancer Manag Res. 2021 Feb 23;13:1877-1886
pubmed: 33654432
Am J Transl Res. 2020 Oct 15;12(10):6314-6324
pubmed: 33194032
Biochem Biophys Res Commun. 2017 Oct 21;492(3):480-486
pubmed: 28834690
Clin Transl Oncol. 2020 Sep;22(9):1524-1531
pubmed: 31965534
J Clin Invest. 2015 Feb;125(2):621-35
pubmed: 25555218
3 Biotech. 2020 Oct;10(10):449
pubmed: 33062578
Sci Rep. 2014 Aug 15;4:6088
pubmed: 25124853
Onco Targets Ther. 2020 Sep 30;13:9741-9751
pubmed: 33061453
Drug Resist Updat. 2020 Mar;49:100673
pubmed: 31877405
Cancer Manag Res. 2020 Jun 18;12:4715-4724
pubmed: 32606962
Bioengineered. 2022 Feb;13(2):2450-2469
pubmed: 35014946
Mol Cancer. 2017 Jul 17;16(1):123
pubmed: 28716020
Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):6647-6656
pubmed: 32633354
Aging (Albany NY). 2019 Oct 10;11(19):8374-8385
pubmed: 31600142
J Cell Physiol. 2021 Mar;236(3):2169-2177
pubmed: 32776544
Mol Biol Rep. 2021 May;48(5):4581-4589
pubmed: 34132945
Cell Death Dis. 2022 Mar 12;13(3):231
pubmed: 35279684
Front Cell Dev Biol. 2022 Feb 16;10:773038
pubmed: 35252166
J Cell Biochem. 2019 Apr;120(4):6781-6788
pubmed: 30382631
Cell Physiol Biochem. 2018;46(6):2445-2459
pubmed: 29742512
Biomed Pharmacother. 2018 Jan;97:543-550
pubmed: 29096355
Mol Cancer. 2018 May 2;17(1):87
pubmed: 29720189
Cell Oncol (Dordr). 2022 Apr;45(2):293-307
pubmed: 35411430
Nat Rev Cancer. 2014 Apr;14(4):233-47
pubmed: 24658274
Cell Death Discov. 2021 Mar 1;7(1):41
pubmed: 33649294
Int J Biochem Cell Biol. 2016 Apr;73:99-110
pubmed: 26860958
J Cancer. 2021 Oct 2;12(22):6905-6920
pubmed: 34659578
Life Sci. 2020 Mar 1;244:116936
pubmed: 31610194
Front Oncol. 2021 Jan 28;10:541410
pubmed: 33585183
Cell Signal. 2022 Mar;91:110216
pubmed: 34920123
Nat Rev Cancer. 2021 Jul;21(7):446-460
pubmed: 33953369
Nat Rev Drug Discov. 2021 Aug;20(8):629-651
pubmed: 34145432
J Neurooncol. 2017 Aug;134(1):19-28
pubmed: 28551849
Apoptosis. 2022 Jun;27(5-6):311-321
pubmed: 35316453
Nat Rev Cancer. 2021 Jan;21(1):22-36
pubmed: 33082563
BMC Cancer. 2021 Feb 8;21(1):142
pubmed: 33557774
FEBS J. 2021 Jun;288(11):3351-3374
pubmed: 33021036
Cell Death Dis. 2021 Jan 14;12(1):83
pubmed: 33446634
Cancer Cell Int. 2019 Nov 20;19:304
pubmed: 31832017
Biochem Biophys Res Commun. 2018 Mar 18;497(4):971-977
pubmed: 29427662
Onco Targets Ther. 2020 Jun 04;13:5033-5046
pubmed: 32581560
Front Oncol. 2022 May 26;12:907472
pubmed: 35692754
Bioessays. 2011 Nov;33(11):851-9
pubmed: 22006825
Insights Cancer Res. 2016;1:1-5
pubmed: 27376155
Tumour Biol. 2016 Oct;37(10):14311-14319
pubmed: 27596142
J Cell Biochem. 2019 Oct;120(10):17131-17141
pubmed: 31173403
Nat Rev Cancer. 2018 Jan;18(1):5-18
pubmed: 29170536
Cancer Cell Int. 2019 Jan 16;19:18
pubmed: 30675129
Gene. 2019 Dec 30;721:144093
pubmed: 31473323
Med Sci Monit. 2019 Jul 10;25:5114-5126
pubmed: 31342947
Biochem Biophys Res Commun. 2016 Sep 16;478(2):507-12
pubmed: 27381864
Mol Biol Rep. 2011 Mar;38(3):1741-7
pubmed: 20878477
Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7816-7825
pubmed: 31599406
J Invest Dermatol. 2020 Dec;140(12):2496-2504
pubmed: 32335130
Front Oncol. 2022 Jan 25;11:726622
pubmed: 35145900
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2956-2962
pubmed: 30135013
Cancer Cell Int. 2020 Feb 28;20:64
pubmed: 32140077
Cell Death Dis. 2022 May 4;13(5):433
pubmed: 35508523
Cell Death Dis. 2021 Oct 12;12(10):930
pubmed: 34642302
Cell Death Dis. 2016 Mar 03;7:e2123
pubmed: 26938295
Biochem Biophys Res Commun. 2019 Jun 18;514(1):140-147
pubmed: 31027732
Onco Targets Ther. 2021 Feb 04;14:795-806
pubmed: 33568918
Lab Invest. 2010 Mar;90(3):414-25
pubmed: 20065949
Biochem Biophys Res Commun. 2014 Aug 8;450(4):1241-6
pubmed: 24973709
Cancer Biother Radiopharm. 2020 Jun;35(5):371-376
pubmed: 32196384
BMC Pulm Med. 2021 May 15;21(1):166
pubmed: 33992085
Eur Rev Med Pharmacol Sci. 2018 May;22(9):2638-2645
pubmed: 29771417
Nat Rev Mol Cell Biol. 2019 Jan;20(1):21-37
pubmed: 30108335
Am J Transl Res. 2019 Jan 15;11(1):245-256
pubmed: 30787983
Nat Commun. 2015 Dec 15;6:10185
pubmed: 26666832
Cell Mol Neurobiol. 2016 Oct;36(7):1097-107
pubmed: 26649728
Free Radic Biol Med. 2022 May 1;184:53-65
pubmed: 35367340
Semin Cancer Biol. 2016 Feb;36:3-17
pubmed: 26416465
Semin Cancer Biol. 2022 Aug;83:303-318
pubmed: 33207266
Cancer Manag Res. 2020 Sep 02;12:7949-7960
pubmed: 32943929
Int J Exp Pathol. 2021 Jun;102(3):163-171
pubmed: 33983643
Nat Med. 2015 Nov;21(11):1253-61
pubmed: 26540387
J Korean Med Sci. 2016 May;31(5):688-94
pubmed: 27134488
J Cell Mol Med. 2019 May;23(5):3224-3233
pubmed: 30887657
Cell Oncol (Dordr). 2021 Aug;44(4):821-834
pubmed: 33974236
Nat Med. 2014 Dec;20(12):1401-9
pubmed: 25419709
Bioengineered. 2021 Dec;12(2):10771-10781
pubmed: 34793263
Transl Cancer Res. 2021 Feb;10(2):738-747
pubmed: 35116405
Biochim Biophys Acta. 2016 Aug;1866(1):12-22
pubmed: 27156687
Sci Rep. 2015 Aug 26;5:13445
pubmed: 26306906
Oncol Rep. 2021 Nov;46(5):
pubmed: 34542165
Tumour Biol. 2015 May;36(5):3355-9
pubmed: 25613066
Neoplasma. 2021 May;68(3):590-601
pubmed: 33780263
Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8113-8118
pubmed: 30556848
J Cell Biochem. 2018 Aug;119(8):6391-6397
pubmed: 29091305
Stem Cells Int. 2021 Nov 23;2021:1075481
pubmed: 34858502
Biomed Pharmacother. 2018 Mar;99:9-17
pubmed: 29324317
Oncol Rep. 2021 Jan;45(1):359-367
pubmed: 33416121
Cell Biol Int. 2020 Mar;44(3):882-893
pubmed: 31829474
Cell Biol Toxicol. 2022 Mar 28;:
pubmed: 35348966
Cancer Manag Res. 2020 May 04;12:3091-3097
pubmed: 32440207
Nat Rev Mol Cell Biol. 2013 Jun;14(6):369-81
pubmed: 23657496
Semin Cancer Biol. 2022 Jun 18;:
pubmed: 35724822
Biofactors. 2020 Jul;46(4):600-607
pubmed: 32049388
Curr Pharm Des. 2015;21(10):1311-7
pubmed: 25506894
Cell Death Dis. 2018 Mar 19;9(4):427
pubmed: 29555946
Oncotarget. 2014 Apr 30;5(8):2000-15
pubmed: 24899581
Mol Ther Nucleic Acids. 2020 Mar 6;19:974-985
pubmed: 32036249
Dig Dis Sci. 2021 Jun;66(6):1885-1894
pubmed: 32820394
Biochim Biophys Acta Rev Cancer. 2021 Apr;1875(2):188502
pubmed: 33428963
Stem Cell Res Ther. 2019 Apr 18;10(1):124
pubmed: 30999935
Medicine (Baltimore). 2018 May;97(21):e10394
pubmed: 29794726
Mol Oncol. 2019 Apr;13(4):840-856
pubmed: 30614188
Mol Cancer. 2022 Feb 4;21(1):36
pubmed: 35120500
FEBS Lett. 2012 May 21;586(10):1409-18
pubmed: 22673505
Oncotarget. 2016 Mar 29;7(13):15787-800
pubmed: 26909858
Am J Transl Res. 2020 Jun 15;12(6):2695-2702
pubmed: 32655801
Biomed Res Int. 2020 Oct 19;2020:7183629
pubmed: 33134385
Pharmacol Ther. 2022 Apr 11;238:108188
pubmed: 35421419
iScience. 2022 Jan 29;25(2):103811
pubmed: 35198876
EMBO Rep. 2011 Dec 23;13(1):36-43
pubmed: 22157894
J Immunol Res. 2022 Feb 21;2022:9557859
pubmed: 35237695
Onco Targets Ther. 2019 Dec 27;12:11531-11539
pubmed: 31920341
Cell Death Dis. 2021 May 21;12(6):524
pubmed: 34021124
Am J Transl Res. 2020 Sep 15;12(9):5481-5495
pubmed: 33042432
Bioengineered. 2021 Dec;12(1):2119-2131
pubmed: 34057016
Mol Med Rep. 2019 Aug;20(2):995-1006
pubmed: 31173223
Oncotarget. 2017 Nov 7;8(68):112530-112549
pubmed: 29348845
Neoplasma. 2019 Jul 23;66(4):564-575
pubmed: 30943745
J Cell Biochem. 2018 Nov 15;:
pubmed: 30444026
Clin Cancer Res. 2018 Jan 15;24(2):486-498
pubmed: 29101304
Eur Rev Med Pharmacol Sci. 2018 Jul;22(13):4204-4214
pubmed: 30024609
Front Oncol. 2022 Feb 21;12:847745
pubmed: 35265529
Mol Cancer. 2021 Sep 8;20(1):116
pubmed: 34496886
Mol Med Rep. 2019 Jul;20(1):182-190
pubmed: 31115514
Mol Cancer. 2022 Mar 26;21(1):87
pubmed: 35346215
Onco Targets Ther. 2020 Oct 19;13:10607-10619
pubmed: 33116638
Chem Biol Drug Des. 2021 Dec 17;:
pubmed: 34918470
Mol Ther Oncolytics. 2021 Apr 20;22:36-51
pubmed: 34401471
Oncol Lett. 2020 Jan;19(1):334-342
pubmed: 31890049
Oncol Lett. 2021 Oct;22(4):718
pubmed: 34429758
Onco Targets Ther. 2020 May 27;13:4799-4811
pubmed: 32547107
Life Sci. 2020 Sep 15;257:118035
pubmed: 32622950
Front Cell Dev Biol. 2020 Aug 31;8:843
pubmed: 32984335
Curr Pharm Des. 2022 Mar 24;:
pubmed: 35331091